Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

38.13
Delayed Data
As of 4:02pm ET
 +0.38 / +1.01%
Today’s Change
25.98
Today|||52-Week Range
41.65
-5.15%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close37.75
Today’s open37.86
Day’s range37.46 - 38.23
Volume256,128
Average volume (3 months)394,260
Market cap$2.0B
Dividend yield--
Data as of 4:02pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-440.62%
Earnings growth (this year)-6.95%
Earnings growth (next 5 years)+8.50%
Revenue growth (last year)+0.02%
P/E ratio123.0
Price/Sales1.97
Price/Book2.66

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc+0.43+1.05%
NXTMNxStage Medical Inc-0.08-0.29%
ICUIICU Medical Inc+1.35+0.89%
PENPenumbra Inc+0.70+0.89%
Data as of 4:02pm ET, 02/21/2017

Financials

Next reporting dateMay 1, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$910.5M
Annual profit (last year)-$55.6M
Net profit margin-6.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Executive Vice President-
Global Operations
Neil Ryding
Corporate headquarters
Braintree, Massachusetts

Forecasts


Search for Jobs